Global Cell Culture Market By Overview
Cell Culture Market accounted for USD 6.52 Billion in 2020 and is estimated to reach USD 14.95 Billion by 2030 and is anticipated to register a CAGR of 8.8%.
Cell Culture refers to the removal of the cells from a plant or an animal, for their subsequent growth in the favorable artificial environment. These cells are removed directly from tissue and disaggregated by mechanical or enzymatic methods before the cultivation. The technique of cell culture was developed in the mid-20th century and then expanded vigorously into different areas such as pharmaceutical research in cancer and immunotherapy. Cell culture is an excellent model system for studying normal biochemistry and physiology, drug effects, and drug screening. Cell culture is an exploratory research field; hence the use of reagents, instruments, and other consumables is very critical to support its advancements. The cell culture is a technique, where the cells are removed from the organisms and placed in the fluid medium to grow. The proper suitable conditions are provided to the cells, where they can live and even grow, which can be further used for the research and development process. Further, the cell culture is emerging as an important tool for clinical testing or diagnosing diseases such as cancer and Alzheimer’s. Hence the companies are also focusing on diversifying their cell depository. Further, the government is also showing its interest in the field of cell culture. For instance, Public Health England (PHE) is the custodian of four unique collections that consist of expertly preserved, authenticated cell lines and microbial strains, which are easily available for use in medical science and laboratory. The increasing application of cell culture in biopharmaceutical industries and vaccine production also favors the growth of cell culture market. For instance, in 2012 the U.S. Food and Drug Administration (FDA) approved the use of Flucelvaz, which was the first U.S.-licensed influenza vaccine manufactured using cell culture technology.
Global Cell Culture Market By Drivers & Restraints
Increasing demand of cancer research is expected to fuel the cell culture market
According the American Cancer Society, in 2017 it was estimated that about 1,688,780 of new cancer cases were expected to be diagnosed. Further, according to World Health Organization (WHO), the cancer accounted for 8.8 Mn of the death worldwide. Such increasing prevalence of cancer demands the extensive research in field of cancer to provide precise treatment.
And as cell culture technique the human cancer cell lines can be used to during the drug discovery and drug screening process, the cell culture market is expected to propel in near future. Further, the advancement in cell culture techniques from production of 2D culture to 3D culture also features more advantages to the researchers supporting the growth of cell culture market. As according the data published in 2012, in Cancer Biology and Therapy Journal showed that the growing cell as 3D spheroids increase resistance to chemotherapy when compared to the same cells grown in monolayer.
Further, the investment by the pharmaceuticals and analytical instrument companies to meet the demand of the cancer population also favor the growth of cell culture market. For instance, in March 2018, Bio-Techne released MinEX GI, a new product line for generating the 5D gastrointestinal tissue on the 2D surface. This tool is expected to be helpful in studying the diseases and disorders of the gastrointestinal tract, such as gastric cancer, celiac disease, and Crohn's disease. The cross contamination during the cell culture hampers the growth of the cell culture market.
Global Cell Culture Market By Segmentations & Regional Insights
The cell culture market on the basis of products, applications, end user, and region.
On the basis of product type, the market is segmented into consumables and instruments. The application segment is further segmented into biopharmaceuticals, vaccine production, gene therapy, cancer research, tissue replacement, drug development, toxicity testing. The end users segment comprises academic and research institutes and pharmaceuticals and biotechnology companies.
Regional Insights:
The Cell Culture Market accounted for US$ 6.52 billion in 2020 and is estimated to be US$ 14.95 billion by 2030 and is anticipated to register a CAGR of 8.8%. For detailed understanding of market dynamics, the cell culture market is analyzed across key regions namely North America, Europe, Asia Pacific, Latin America, Africa, and Middle East. Each of these regions is analyzed on basis of market findings across major countries in these regions for a macro-level understanding of the market.
Cell Culture Market, By Product Type:
- Instruments
- Consumables
Cell Culture Market, By Application:
- Biopharmaceuticals
- Vaccine Production
- Gene Therapy
- Cancer Research
- Tissue Replacement
- Drug Development
- Toxicity Testing
Cell Culture Market, By End User:
- Academic & Research Institutions
- Pharmaceutical and Biotechnology Companies
Cell Culture Market, By Region:
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
Global Cell Culture Market By Competitive Landscape & Key Players
The key players operating the cell culture market includes Sigma - Aldrich Corporation, Thermo Fisher Scientific, Inc., Becton, Dickinson and Company, EMD Millipore, Sartorius AG, Merck KGAA, Biospherix and Biovest International Inc
Global Cell Culture Market By Company Profile
- Sigma - Aldrich Corporation
- Thermo Fisher Scientific, Inc.
- Becton, Dickinson, and Company
- EMD Millipore
- Sartorius AG,
- Merck KGAA
- Biospherix
- Biovest International Inc
FAQs
The market is segmented into By Product Type (Instruments and Consumables), By Application (Biopharmaceuticals, Vaccine Production, Gene Therapy, Cancer Research, Tissue Replacement, Drug Development, and Toxicity Testing), By End User (Academic & Research Institutions, and Pharmaceutical and Biotechnology Companies)
The advancement in cell culture techniques from production of 2D culture to 3D culture also features more advantages to the researchers supporting the growth of cell culture market. As according the data published in 2012, in Cancer Biology and Therapy Journal showed that the growing cell as 3D spheroids increase resistance to chemotherapy when compared to the same cells grown in monolayer.
The North America dominates the cell culture market owing to increasing presence of biopharmaceutical industries with increasing demand of precision medicine.
Key players operating the cell culture market, include Sigma Aldrich Corporation, Thermo Fisher Scientific, Inc., Becton, Dickinson and Company, EMD Millipore, Sartorius AG, Merck KGAA, Biospherix and Biovest International Inc
High cost of the drug is the major restrain for this market.